Loading organizations...
Rune Labs develops precision neurology software and data analytics platforms, enhancing care and accelerating therapy development. Its StrivePD ecosystem gathers real-world patient data from wearables, offering clinicians personalized Parkinson's disease symptom summaries. This approach optimizes treatment pathways and drives novel therapy advancements for neurodegenerative conditions.
Brian Pepin founded Rune Labs in San Francisco in October 2018. The company emerged from the insight that clinical brain data held immense, underutilized potential to transform patient care. Pepin aimed to translate complex neurotechnology data into actionable, personalized treatment strategies, bridging raw data with effective neurological disorder management.
Rune Labs serves clinicians with curated patient data dashboards and supports life sciences organizations with real-world evidence for clinical trials. Its vision is to revolutionize neurological care and accelerate disease-modifying therapy discovery via data-driven insights. The company expands across diverse neurodegenerative conditions, fostering precise, patient-centric brain treatments.
Rune Labs has raised $52.0M across 4 funding rounds.
Rune Labs has raised $52.0M in total across 4 funding rounds.
Rune Labs has raised $52.0M in total across 4 funding rounds.
Rune Labs's investors include Jordi Parramon, DigiTx Partners, Eclipse, Moment Ventures, TruVenturo, Nexus NeuroTech Ventures, Eclipse Ventures, Foundation Capital, Pathbreaker Ventures, Softbank Group, David Kim, MD, Daybreak Partners.
Rune Labs has raised $52.0M across 4 funding rounds. Most recently, it raised $12.0M Other Equity in January 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 11, 2024 | $12M Venture Round | Jordi Parramon | DigiTx Partners, Eclipse, Moment Ventures, TruVenturo | Announced |
| Jan 1, 2024 | $12M Series U | Nexus Neurotech Ventures | Eclipse Ventures, Foundation Capital, Pathbreaker Ventures, Softbank Group, DigiTx Partners, Moment Ventures, TruVenturo | Announced |
| Sep 1, 2021 | $23M Series A | Eclipse Ventures | Foundation Capital, Pathbreaker Ventures, Softbank Group, David Kim, MD, Moment Ventures | Announced |
| Sep 1, 2020 | $5M Seed | David Kim, MD | Daybreak Partners, Eclipse Ventures, Loup Ventures, Moment Ventures, Sabbatical Ventures, TruVenturo | Announced |
Rune Labs is a San Francisco–based healthcare software company that builds a secure, cloud-native data and analytics platform to organize time-series brain signals and clinical data for precision neurology—especially Parkinson’s disease—and to accelerate neuromodulation and drug development programs[5][4].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick tie‑back: Rune Labs’ focused combination of time‑series brain data infrastructure, clinical workflows (StrivePD), and industry integrations positions it as a pragmatic enabler for precision neurology—bridging device telemetry, clinical care and therapy development to accelerate better treatments for brain disease[4][5].